Dana dhuwit diétung saben saham Traws Pharma Inc (TRAW)

Lambang korporat lan logo Traws Pharma (TRAW)

Traws Pharma, Inc. (TRAW) is creating a closed oral therapy system, locking in medical centers through exclusive inhibitor patents. The cash per share metric reflects liquidity dynamics, where the current value is 0.33. The biotech's financial standing is currently tied to external investments and test results. Capital mobility is maintained by outsourcing research to third-party CRO contractors.

Traws Therapeutics (TRAW) - Dana dhuwit saben saham saka 04.04.2024 nganti 20.11.2026

Rincian metrik komprehensif lan analitis Traws Therapeutics (TRAW)

- nilai saham lan prakiraan konsensus rega:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:Traws Pharma Inc - TRAW
Barang unggulan Traws Pharma Inc

The metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. This metric reflects the actual value of cash backing for each share, eliminating distortions from quarterly reporting. For Traws Pharma, Inc. (TRAW), which is debt-free, the value of 0.33 confirms high financial autonomy in the development of antiviral agents. An analysis of the cash per share calculation allows for an assessment of capital stability. The dynamics in this cash per share calculation minimize the risks of deep drawdowns.